215 related articles for article (PubMed ID: 12176625)
21. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
22. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin.
Schulz T; Martin D; Heimes M; Klempnauer J; Buesing M
Transplant Proc; 1998 Jun; 30(4):1533-5. PubMed ID: 9636623
[No Abstract] [Full Text] [Related]
23. Tacrolimus in solid organ transplantation: an update.
Shapiro R
Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
[No Abstract] [Full Text] [Related]
24. Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras.
Jang HJ; Kim SC; Han DJ
Transplant Proc; 2000 Nov; 32(7):2470-1. PubMed ID: 11120249
[No Abstract] [Full Text] [Related]
25. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
[TBL] [Abstract][Full Text] [Related]
26. Sequential pancreas after kidney transplantation: is anti-lymphocyte induction therapy needed?
Stratta RJ
Transplant Proc; 1998 Jun; 30(4):1549-51. PubMed ID: 9636629
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Sudan R; Sudan D
Transplant Proc; 1998 Jun; 30(4):1564-5. PubMed ID: 9636635
[No Abstract] [Full Text] [Related]
29. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Fabrega AJ; Corwin CL; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
[No Abstract] [Full Text] [Related]
30. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
[No Abstract] [Full Text] [Related]
31. Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation.
Boggi U; Vistoli F; Coppelli A; Marchetti P; Rizzo G; Mosca F
Transplant Proc; 2001; 33(7-8):3201-2. PubMed ID: 11750373
[No Abstract] [Full Text] [Related]
32. FK 506-based immunosuppression in clinical pancreas transplantation.
Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
[No Abstract] [Full Text] [Related]
33. Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
Teraoka S; Babazono T; Koike T; Abe M; Kimikawa M; Shinkai M; Haruguchi H; Hirotani S; Kitajima K; Akamatsu M
Transplant Proc; 1995 Feb; 27(1):1335-9. PubMed ID: 7533381
[No Abstract] [Full Text] [Related]
34. Pancreas transplantation in cross-match-positive recipients using cyclosporine- or tacrolimus-based immunosuppression.
Khwaja K; Wijkstrom M; Gruessner A; Noreen H; Sutherland DE; Gruessner RW
Transplant Proc; 2002 Aug; 34(5):1901-2. PubMed ID: 12176621
[No Abstract] [Full Text] [Related]
35. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
36. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
[No Abstract] [Full Text] [Related]
37. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
[No Abstract] [Full Text] [Related]
38. Can we improve the results of simultaneous pancreas-kidney transplantation?
Fornairon S; Desgrandchamps F; Cattan P; Meria P; Anidjar M; Bedrossian J; Teillac P; Le Duc A; Legendre C
Transplant Proc; 1998 Sep; 30(6):2818-9. PubMed ID: 9745580
[No Abstract] [Full Text] [Related]
39. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Washburn WK; Shaffer D; Simpson MA; Conway P; Madras PN; Monaco AP
Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
[No Abstract] [Full Text] [Related]
40. Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
Hariharan S; Peddi VR; Munda R; Demmy AM; Schroeder TJ; Alexander JW; First MR
Transplant Proc; 1997; 29(1-2):652-3. PubMed ID: 9123462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
